Mazdutide 10mg

Description

Mazdutide 10mg is a dual GLP-1 and glucagon receptor agonist developed for research into metabolic signaling, glucose regulation, appetite, and energy balance.

Its dual-receptor mechanism makes mazdutide particularly interesting within the rapidly evolving incretin research category. GLP-1 receptor activation is associated with satiety and glucose-dependent metabolic signaling, while glucagon receptor activity plays an important role in hepatic and whole-body energy metabolism.

This combination has led researchers to investigate whether simultaneously targeting both pathways may produce metabolic effects that differ from compounds acting primarily through GLP-1 alone. Clinical studies have evaluated mazdutide across several doses in subjects with overweight, obesity, and metabolic disease. 

Common research areas: GLP-1 signaling, glucagon signaling, metabolic regulation, appetite pathways, glucose metabolism, energy expenditure, and body-weight regulation.

Product Strength: 10mg

Mazdutide’s regulatory status is worth describing accurately: it has received NMPA approval in China for chronic weight management and for glycemic control in adults with type 2 diabetes. It is not the same as saying that mazdutide has FDA approval in the United States.